Case report and review demonstrates remission following pembrolizumab rechallenge in metastatic sinonasal carcinoma after severe pneumonitis, suggesting careful immunotherapy reintroduction is viable.
No takes yet. Share an insight, caveat, or question.
Nair et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: